Table 7. Progress towards viral hepatitis elimination targets for 2025 outlined in the Global Health Sector Strategy 2022–2030, Canada, 2021.
| Indicator | 2025 target ((11)) | 2021 estimates | Reference(s) |
|---|---|---|---|
| Hepatitis B | |||
| Hepatitis B surface antigen prevalence among children 0–4 years old | 0.5% | Additional data needed | |
| Number of new hepatitis B infections per year | 11/100,000 population | Additional data needed | |
| Number of people dying from hepatitis B per year | 7/100,000 population | 0.72/100,000 population | This study using Vital statistics data ((18)) |
| Percentage of newborns who have benefitted from a timely birth dose of hepatitis vaccine and from other interventions to prevent the vertical (mother-to-child) transmission of hepatitis B virus | 70% | Less than 2% | This study using Vital statistics data ((18)) |
| Hepatitis B vaccine coverage among children (third dose)a | 90% | 89.0% among 14-year-olds, 1 or more dose |
((17)) |
| Percentage of people living with hepatitis B diagnosed | 60% | 57.5% | This study |
| Percentage of people living with hepatitis B diagnosed and treated | 50% | Additional data needed | |
| Hepatitis C | |||
| Number of new hepatitis C infections per year | 13/100,000 population | 21.47/100,000 population | This study |
| Number of new hepatitis C infections among PWID per year | 3/100 | Additional data needed | |
| Number of people dying from hepatitis C per year | 3/100,000 population | 2.54/100,000 population | This study using Vital statistics data ((18)) |
| Number of needles and syringes distributed per PWID | 200 | Additional data needed | |
| Blood safety: proportion of blood units screened for blood-borne diseases | 100% | 100% of blood donations are tested for hepatitis B and C | ((59)) |
| Safe injections: proportion of safe healthcare injections | 100% | Additional data needed | |
| Percentage of people living with hepatitis C diagnosed | 60% | 58.5% | This study |
| Percentage of people living with hepatitis C diagnosed and cured | 50% | Additional data needed | |
Abbreviation: PWID, people who inject drugs
a The domestic vaccine coverage goal in Canada is to achieve 90% vaccination coverage by 17 years of age for one or more doses of the hepatitis B vaccine, by 2025 ((60)). As of 2024, no other domestic targets were set